Novartis | NOVN - Efectivo Y Equivalentes

Precio De Mercado
115.90
Cambio Diario
2.56 2.26%
Mensual
-4.10%
Anual
23.02%
Q2 Expectativa
111.47




Efectivo Y Equivalentes Cambio Fecha
AbbVie USD 5.23B 400M 2025-12
Alcon AG USD 1.5B 90M 2025-09
Almirall EUR 337.77M 14.83M 2025-12
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 7.56B 1.85B 2026-03
Autolus Therapeutics Ltd USD 104.13M 18.01M 2025-12
Bayer EUR 5.9B 1.34B 2025-09
Biogen USD 3.38B 374.2M 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Eli Lilly USD 5.28B 1.99B 2026-03
Fresenius EUR 1.23B 1.16B 2025-06
Fresenius Medical Care EUR 1.58B 326.57M 2025-12
Galapagos EUR 87.87M 23.41M 2025-12
Genmab DKK 1.72B 46M 2025-12
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
GRIFOLS EUR 801M 242.31M 2025-12
Hikma Pharmaceutical USD 236M 48M 2025-06
J&J USD 21.69B 1.98B 2026-03
Lonza CHF 719M 188M 2025-12
Merck EUR 2.25B 1.08B 2025-09
Merck USD 14.57B 3.6B 2025-12
Novartis USD 11.44B 1.88B 2025-12
Novartis USD 9.56B 2.9B 2025-09
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Orion EUR 160.9M 63.3M 2025-12
Pfizer USD 1.34B 295M 2025-09
Philips EUR 1.91B 90M 2025-09
Recordati EUR 471.46M 129.91M 2025-09
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
UCB EUR 1.57B 1.14B 2024-12